Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study

Authors:
Firas Abdollah From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Firas Abdollah in
Current site
Google Scholar
PubMed Close
 MD
,
Jesse D. Sammon From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Jesse D. Sammon in
Current site
Google Scholar
PubMed Close
 DO
,
Kaustav Majumder From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Kaustav Majumder in
Current site
Google Scholar
PubMed Close
 MD
,
Gally Reznor From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Gally Reznor in
Current site
Google Scholar
PubMed Close
 BS, MBS
,
Giorgio Gandaglia From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Giorgio Gandaglia in
Current site
Google Scholar
PubMed Close
 MD
,
Akshay Sood From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Akshay Sood in
Current site
Google Scholar
PubMed Close
 MD
,
Nathanael Hevelone From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Nathanael Hevelone in
Current site
Google Scholar
PubMed Close
 MS
,
Adam S. Kibel From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Adam S. Kibel in
Current site
Google Scholar
PubMed Close
 MD
,
Paul L. Nguyen From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Paul L. Nguyen in
Current site
Google Scholar
PubMed Close
 MD
,
Toni K. Choueiri From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Toni K. Choueiri in
Current site
Google Scholar
PubMed Close
 MD
,
Kathy J. Selvaggi From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Kathy J. Selvaggi in
Current site
Google Scholar
PubMed Close
 MD
,
Mani Menon From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Mani Menon in
Current site
Google Scholar
PubMed Close
 MD
, and
Quoc-Dien Trinh From the Center for Outcomes Research, Analytics and Evaluation, Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan; Department of Surgery, University of Minnesota, Minneapolis, Minnesota; Division of Urologic Surgery and Center for Surgery and Public Health, Department of Radiation Oncology, Department of Medical Oncology, and Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Search for other papers by Quoc-Dien Trinh in
Current site
Google Scholar
PubMed Close
 MD
Volume/Issue:
Volume 13: Issue 9
Online Publication Date:
Sep 2015
DOI:
https://doi.org/10.6004/jnccn.2015.0138
Restricted access

Objective: To examine racial disparities in end-of-life (EOL) care among black and white patients dying of prostate cancer (PCa). Methods: Relying on the SEER-Medicare database, 3789 patients who died of metastatic PCa between 1999 and 2009 were identified. Information was assessed regarding diagnostic care, therapeutic interventions, hospitalizations, intensive care unit (ICU) admissions, and emergency department visits in the last 12 months, 3 months, and 1 month of life. Logistic regression tested the relationship between race and the receipt of diagnostic care, therapeutic interventions, and high-intensity EOL care. Results: Overall, 729 patients (19.24%) were black. In the 12-months preceding death, laboratory tests (odds ratio [OR], 0.51; 95% CI, 0.36–0.72), prostate-specific antigen test (OR, 0.54; 95% CI, 0.43–0.67), cystourethroscopy (OR, 0.71; 95% CI, 0.56–0.90), imaging procedure (OR, 0.58; 95% CI, 0.41–0.81), hormonal therapy (OR, 0.53; 95% CI, 0.44–0.65), chemotherapy (OR, 0.59; 95% CI, 0.48–0.72), radiotherapy (OR, 0.74; 95% CI, 0.61–0.90), and office visit (OR, 0.38; 95% CI, 0.28–0.50) were less frequent in black versus white patients. Conversely, high-intensity EOL care, such as ICU admission (OR, 1.27; 95% CI, 1.04–1.58), inpatient admission (OR, 1.49; 95% CI, 1.09–2.05), and cardiopulmonary resuscitation (OR, 1.72; 95% CI, 1.40–2.11), was more frequent in black versus white patients. Similar trends for EOL care were observed at 3-month and 1-month end points. Conclusions: Although diagnostic and therapeutic interventions are less frequent in black patients with end-stage PCa, the rate of high-intensity and aggressive EOL care is higher in these individuals. These disparities may indicate that race plays an important role in the quality of care for men with end-stage PCa.

Correspondence: Firas Abdollah, MD, Vattikuti Urology Institute & VUI Center for Outcomes Research Analytics and Evaluation, Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202-2689. E-mail: firas.abdollah@gmail.com, fabdoll1@hfhs.org

Supplementary Materials

    • Supplemental Material (PDF 101 KB)
  • Collapse
  • Expand
Print ISSN:
1540-1405
Online ISSN:
1540-1413
Publisher:
National Comprehensive Cancer Network
Cover Journal of the National Comprehensive Cancer Network
Copyright:
Copyright © 2015 by the National Comprehensive Cancer Network 2015
Page Numbers:
8
Article Category:
Research Article
Received:
27 Jan 2015
Accepted:
16 Jul 2015
Print Publication Date:
01 Sep 2015
Online Publication Date:
Sep 2015

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 2249 696 118
PDF Downloads 739 177 10
EPUB Downloads 0 0 0